Metabolic Signatures of Surface-Modified Poly(lactic-<i>co</i>-glycolic acid) Nanoparticles in Differentiated THP-1 Cells Derived with Liquid Chromatography-Mass Spectrometry-based Metabolomics-Reference-Cited by-同舟云学术

Metabolic Signatures of Surface-Modified Poly(lactic-co-glycolic acid) Nanoparticles in Differentiated THP-1 Cells Derived with Liquid Chromatography-Mass Spectrometry-based Metabolomics

Published:2022-08-12 Issue:33 Volume:7 Page:28806-28819
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Al-natour Mohammad A.¹²,Abdelrazig Salah³⁴^ORCID,Ghaemmaghami Amir M.⁵^ORCID,Alexander Cameron¹^ORCID,Kim Dong-Hyun³^ORCID

Affiliation:

1. Molecular Therapeutics and Formulation Division, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, U.K.

2. Division of Pharmaceutics and Pharmaceutical Sciences, Faculty of Pharmacy, University of Petra, Amman 11196, Jordan

3. Centre for Analytical Bioscience, Advanced Materials and Healthcare Technologies Division, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, U.K.

4. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Khartoum, Khartoum 11115, Sudan

5. Immunology & Immuno-bioengineering Group, School of Life Sciences, Faculty of Medicine and Health Sciences, Queen’s Medical Centre, University of Nottingham, Nottingham NG7 2RD, U.K.

Funder

Engineering and Physical Sciences Research Council

Royal Society

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.2c01660

Reference63 articles.

1. An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021)

2. Targeting a rare amyloidotic disease through rationally designed polymer conjugates

3. PLGA-Based Drug Delivery Systems for Remotely Triggered Cancer Therapeutic and Diagnostic Applications

4. Reduction‐responsive polymers for drug delivery in cancer therapy—Is there anything new to discover?

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Facile Rebridging Conjugation Approach to Attain Monoclonal Antibody-Targeted Nanoparticles with Enhanced Antigen Binding and Payload Delivery;Bioconjugate Chemistry;2024-09-10

2. Study on the metabolic effects of hexavalent chromium [Cr (VI)] on rat astrocytes using un-targeted metabolomics;Frontiers in Molecular Biosciences;2024-07-05

3. Effects of multi‐walled carbon nanotubes and halloysite nanotubes on plasma lipid profiles and autophagic lipolysis pathways in mouse aortas and hearts;Environmental Toxicology;2024-06-10

4. Metabolomics-directed nanotechnology in viral diseases management: COVID-19 a case study;Pharmacological Reports;2023-08-16